Skip to content

Influence of the Sleep Pattern in Patients Submitted to Bariatric Surgery

Influence of the Sleep and Chronotype Pattern in Metabolic, Anthropometric and Biochemical Responses in Patients Submitted to Bariatric Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03485352
Enrollment
122
Registered
2018-04-02
Start date
2017-06-05
Completion date
2019-04-30
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Candidate

Keywords

Bariatric Surgery, Sleep, Chronotype

Brief summary

The present study has a prospective, longitudinal and observational character, will be performed with patients attending a private clinic specialized in the treatment of obesity and bariatric surgery. Patients to be analyzed should have a medical indication for bariatric surgery.

Detailed description

The patients will be selected for ten months and will be monitored for 12 months there are preoperative period, 3 months, 6 months and 12 months after surgery. Anthropometrical evaluation, biochemistry, polysomnography and sleep questionnaire (Epworth and Psqi) and midpoint sleep questionnaires will be performed to classify the chronotype for sleep pattern evaluation.

Interventions

None listed

Sponsors

Federal University of Uberlandia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years

Inclusion criteria

* Agree to participate in the study and sign the Informed Consent Form (EHIC) * Patients submitted to By-pass or Sleeve bariatric surgery or Endossleve * Patients with BMI above 35 kg / m². * Over the age of 18 and up to 60 years.

Exclusion criteria

* Failure to provide the information necessary for the development of the study. * Patients undergo revisional surgery

Design outcomes

Primary

MeasureTime frameDescription
Metabolic Parameters - Triglycerides (mg/dl)Baseline and 6 monthsMetabolic parameters will be evaluated using Triglycerides (mg/dl)
Metabolic Parameters - Homeostasis Model Assessment for Beta-cell Function (HOMA - IR)Baseline and 6 monthsValues of metabolic parameters will be evaluated using Homeostasis model assessment for beta-cell function (HOMA - IR) according to the standard assessment measurement in mg/dl. Higher values reflect worse insulin resistance
Metabolic Parameters - Cholesterol (mg/dl)Baseline and 6 monthsMetabolic parameters will be evaluated using Cholesterol (mg/dl)
Metabolic Parameters - High Density Lipoprotein Cholesterol (HDL - mg/dl)Baseline and 6 monthsMetabolic parameters will be evaluated using High density lipoprotein cholesterol (HDL - mg/dl)
Metabolic Parameters - Low Density Lipoprotein Cholesterol (LDL - mg/dl)Baseline and 6 monthsMetabolic parameters will be evaluated using low density lipoprotein cholesterol (LDL -mg/dl)
Metabolic Parameters - Very Low Density Lipoprotein Cholesterol (VLDL - mg/dl)Baseline and 6 monthsMetabolic parameters will be evaluated using Very low density lipoprotein cholesterol (VLDL - mg/dl)
Weight in KgBaseline, 3 and 6 monthsAnthropometric assessment will be evaluated using weight (kg).
BMI in Kg/m²Baseline, 3 and 6 monthsAnthropometric assessment will be evaluated using BMI (kg/m²).
Waist Circumference in Centimeters (cm)Baseline, 3 and 6 monthsAnthropometric assessment will be evaluated using waist circumference (cm)
Hip Circumference in Centimeters (cm)Baseline, 3 and 6 monthsAnthropometric assessment will be evaluated using hip circumference (cm)
Neck Circumference in Centimeters (cm)Baseline, 3 and 6 monthsAnthropometric assessment will be evaluated using neck circumference (cm)
Metabolic Parameters - Fasting Glucose (mg/dl)Baseline and 6 monthsMetabolic parameters will be evaluated using fasting glucose (mg/dl)
Metabolic Parameters - Insulin (mg/dl)Baseline and 6 monthsMetabolic parameters will be evaluated using insulin (mg/dl)

Secondary

MeasureTime frameDescription
Food Consumption - Carbohydrate (Grams/Day)Baseline, 3 and 6 monthsThe food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).
Food Consumption - Total Fat (Grams/Day)Baseline, 3 and 6 monthsThe food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).
Food Consumption - Polyunsaturated Fat (Grams/Day)Baseline, 3 and 6 monthsThe food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).
Food Consumption - Monounsaturated Fat (Grams/Day)Baseline, 3 and 6 monthsThe food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).
Food Consumption - Calories (Grams/Day)Baseline, 3 and 6 monthsThe food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).

Countries

Brazil

Participant flow

Participants by arm

ArmCount
Small SJL
Patients who underwent bariatric surgery - Roux-en-Y gastric bypass (80%) or Sleeve (20%), female (80%)
60
Large SJL
Patients who underwent bariatric surgery - Roux-en-Y gastric bypass (79%) or Sleeve (21%), female (74%)
62
Total122

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up9

Baseline characteristics

CharacteristicTotalSmall SJLLarge SJL
Age, Continuous33 years33.5 years33 years
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
94 Participants48 Participants46 Participants
Sex: Female, Male
Male
28 Participants12 Participants16 Participants
Social jetlag exposure67 Minutes67 Minutes67 Minutes

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 122
other
Total, other adverse events
0 / 122
serious
Total, serious adverse events
0 / 122

Outcome results

Primary

BMI in Kg/m²

Anthropometric assessment will be evaluated using BMI (kg/m²).

Time frame: Baseline, 3 and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of BMI in the preoperative evaluation and in the third and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLBMI in Kg/m²Baseline40.8 Kg/m²Standard Error 0.4
Small SJLBMI in Kg/m²3 months32.9 Kg/m²Standard Error 0.4
Small SJLBMI in Kg/m²6 months28.7 Kg/m²Standard Error 0.4
Large SJLBMI in Kg/m²Baseline41.8 Kg/m²Standard Error 0.8
Large SJLBMI in Kg/m²3 months33.6 Kg/m²Standard Error 0.7
Large SJLBMI in Kg/m²6 months30.2 Kg/m²Standard Error 0.7
Primary

Hip Circumference in Centimeters (cm)

Anthropometric assessment will be evaluated using hip circumference (cm)

Time frame: Baseline, 3 and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of hip circumference in the preoperative evaluation and in the third and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLHip Circumference in Centimeters (cm)Baseline128.9 CentimetersStandard Error 1.1
Small SJLHip Circumference in Centimeters (cm)3 months114.9 CentimetersStandard Error 1.1
Small SJLHip Circumference in Centimeters (cm)6 months105.8 CentimetersStandard Error 1
Large SJLHip Circumference in Centimeters (cm)Baseline131.4 CentimetersStandard Error 1.7
Large SJLHip Circumference in Centimeters (cm)3 months117.8 CentimetersStandard Error 1.7
Large SJLHip Circumference in Centimeters (cm)6 months109.9 CentimetersStandard Error 1.6
Primary

Metabolic Parameters - Cholesterol (mg/dl)

Metabolic parameters will be evaluated using Cholesterol (mg/dl)

Time frame: Baseline and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of cholesterol in the preoperative evaluation and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLMetabolic Parameters - Cholesterol (mg/dl)Baseline201.6 mg/dlStandard Error 5.3
Small SJLMetabolic Parameters - Cholesterol (mg/dl)6 months157.0 mg/dlStandard Error 4.2
Large SJLMetabolic Parameters - Cholesterol (mg/dl)Baseline203.9 mg/dlStandard Error 5.4
Large SJLMetabolic Parameters - Cholesterol (mg/dl)6 months159.5 mg/dlStandard Error 4.6
Primary

Metabolic Parameters - Fasting Glucose (mg/dl)

Metabolic parameters will be evaluated using fasting glucose (mg/dl)

Time frame: Baseline and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of fasting glucose in the preoperative evaluation and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLMetabolic Parameters - Fasting Glucose (mg/dl)Baseline99.0 mg/dlStandard Error 1.7
Small SJLMetabolic Parameters - Fasting Glucose (mg/dl)6 months84.5 mg/dlStandard Error 1.1
Large SJLMetabolic Parameters - Fasting Glucose (mg/dl)Baseline101.2 mg/dlStandard Error 3.6
Large SJLMetabolic Parameters - Fasting Glucose (mg/dl)6 months83.3 mg/dlStandard Error 0.8
Primary

Metabolic Parameters - High Density Lipoprotein Cholesterol (HDL - mg/dl)

Metabolic parameters will be evaluated using High density lipoprotein cholesterol (HDL - mg/dl)

Time frame: Baseline and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of HDL in the preoperative evaluation and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLMetabolic Parameters - High Density Lipoprotein Cholesterol (HDL - mg/dl)Baseline51.4 mg/dlStandard Error 1.7
Small SJLMetabolic Parameters - High Density Lipoprotein Cholesterol (HDL - mg/dl)6 months52.1 mg/dlStandard Error 1.6
Large SJLMetabolic Parameters - High Density Lipoprotein Cholesterol (HDL - mg/dl)Baseline47.6 mg/dlStandard Error 1.6
Large SJLMetabolic Parameters - High Density Lipoprotein Cholesterol (HDL - mg/dl)6 months47.1 mg/dlStandard Error 1.5
Primary

Metabolic Parameters - Homeostasis Model Assessment for Beta-cell Function (HOMA - IR)

Values of metabolic parameters will be evaluated using Homeostasis model assessment for beta-cell function (HOMA - IR) according to the standard assessment measurement in mg/dl. Higher values reflect worse insulin resistance

Time frame: Baseline and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of HOMA IR in the preoperative evaluation and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLMetabolic Parameters - Homeostasis Model Assessment for Beta-cell Function (HOMA - IR)Baseline6.7 mg/dlStandard Error 0.5
Small SJLMetabolic Parameters - Homeostasis Model Assessment for Beta-cell Function (HOMA - IR)6 months1.8 mg/dlStandard Error 0.2
Large SJLMetabolic Parameters - Homeostasis Model Assessment for Beta-cell Function (HOMA - IR)Baseline6.2 mg/dlStandard Error 0.4
Large SJLMetabolic Parameters - Homeostasis Model Assessment for Beta-cell Function (HOMA - IR)6 months2.1 mg/dlStandard Error 0.1
Primary

Metabolic Parameters - Insulin (mg/dl)

Metabolic parameters will be evaluated using insulin (mg/dl)

Time frame: Baseline and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of insulin in the preoperative evaluation and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLMetabolic Parameters - Insulin (mg/dl)Baseline27.0 mg/dlStandard Error 2.1
Small SJLMetabolic Parameters - Insulin (mg/dl)6 months8.8 mg/dlStandard Error 0.9
Large SJLMetabolic Parameters - Insulin (mg/dl)Baseline25.2 mg/dlStandard Error 1.6
Large SJLMetabolic Parameters - Insulin (mg/dl)6 months10.5 mg/dlStandard Error 0.6
Primary

Metabolic Parameters - Low Density Lipoprotein Cholesterol (LDL - mg/dl)

Metabolic parameters will be evaluated using low density lipoprotein cholesterol (LDL -mg/dl)

Time frame: Baseline and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of LDL in the preoperative evaluation and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLMetabolic Parameters - Low Density Lipoprotein Cholesterol (LDL - mg/dl)Baseline118.0 mg/dlStandard Error 4.4
Small SJLMetabolic Parameters - Low Density Lipoprotein Cholesterol (LDL - mg/dl)6 months86.0 mg/dlStandard Error 3.5
Large SJLMetabolic Parameters - Low Density Lipoprotein Cholesterol (LDL - mg/dl)Baseline119.8 mg/dlStandard Error 4.3
Large SJLMetabolic Parameters - Low Density Lipoprotein Cholesterol (LDL - mg/dl)6 months92.9 mg/dlStandard Error 3.8
Primary

Metabolic Parameters - Triglycerides (mg/dl)

Metabolic parameters will be evaluated using Triglycerides (mg/dl)

Time frame: Baseline and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of triglycerides in the preoperative evaluation and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLMetabolic Parameters - Triglycerides (mg/dl)Baseline162.9 mg/dlStandard Error 10.6
Small SJLMetabolic Parameters - Triglycerides (mg/dl)6 months98.8 mg/dlStandard Error 5.7
Large SJLMetabolic Parameters - Triglycerides (mg/dl)Baseline162.3 mg/dlStandard Error 9
Large SJLMetabolic Parameters - Triglycerides (mg/dl)6 months96.0 mg/dlStandard Error 4.6
Primary

Metabolic Parameters - Very Low Density Lipoprotein Cholesterol (VLDL - mg/dl)

Metabolic parameters will be evaluated using Very low density lipoprotein cholesterol (VLDL - mg/dl)

Time frame: Baseline and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of VLDL in the preoperative evaluation and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLMetabolic Parameters - Very Low Density Lipoprotein Cholesterol (VLDL - mg/dl)Baseline32.2 mg/dlStandard Error 2.6
Small SJLMetabolic Parameters - Very Low Density Lipoprotein Cholesterol (VLDL - mg/dl)6 months19.3 mg/dlStandard Error 0.9
Large SJLMetabolic Parameters - Very Low Density Lipoprotein Cholesterol (VLDL - mg/dl)Baseline36.4 mg/dlStandard Error 2.9
Large SJLMetabolic Parameters - Very Low Density Lipoprotein Cholesterol (VLDL - mg/dl)6 months19.4 mg/dlStandard Error 1.1
Primary

Neck Circumference in Centimeters (cm)

Anthropometric assessment will be evaluated using neck circumference (cm)

Time frame: Baseline, 3 and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of neck circumference in the preoperative evaluation and in the third and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLNeck Circumference in Centimeters (cm)3 months36.0 CentimetersStandard Error 0.4
Small SJLNeck Circumference in Centimeters (cm)Baseline39.2 CentimetersStandard Error 0.4
Small SJLNeck Circumference in Centimeters (cm)6 months34.4 CentimetersStandard Error 0.3
Large SJLNeck Circumference in Centimeters (cm)Baseline39.4 CentimetersStandard Error 0.5
Large SJLNeck Circumference in Centimeters (cm)3 months36.3 CentimetersStandard Error 0.4
Large SJLNeck Circumference in Centimeters (cm)6 months35.1 CentimetersStandard Error 0.4
Primary

Waist Circumference in Centimeters (cm)

Anthropometric assessment will be evaluated using waist circumference (cm)

Time frame: Baseline, 3 and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of waist circumference in the preoperative evaluation and in the third and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLWaist Circumference in Centimeters (cm)3 months94.1 CentimetersStandard Error 1.2
Small SJLWaist Circumference in Centimeters (cm)6 months85.5 CentimetersStandard Error 1.1
Small SJLWaist Circumference in Centimeters (cm)Baseline109.3 CentimetersStandard Error 1.4
Large SJLWaist Circumference in Centimeters (cm)3 months95.1 CentimetersStandard Error 1.4
Large SJLWaist Circumference in Centimeters (cm)6 months88.4 CentimetersStandard Error 1.4
Large SJLWaist Circumference in Centimeters (cm)Baseline110.0 CentimetersStandard Error 1.7
Primary

Weight in Kg

Anthropometric assessment will be evaluated using weight (kg).

Time frame: Baseline, 3 and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of weight in the preoperative evaluation and in the third and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLWeight in KgBaseline111.4 KgStandard Error 2.1
Small SJLWeight in Kg3 months89.7 KgStandard Error 1.7
Small SJLWeight in Kg6 months77.5 KgStandard Error 1.5
Large SJLWeight in KgBaseline116.4 KgStandard Error 3.3
Large SJLWeight in Kg3 months93.5 KgStandard Error 2.7
Large SJLWeight in Kg6 months84.2 KgStandard Error 2.6
Secondary

Food Consumption - Calories (Grams/Day)

The food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).

Time frame: Baseline, 3 and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of food consumption of calories in the preoperative evaluation and in the third and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLFood Consumption - Calories (Grams/Day)Baseline2185.0 grams/dayStandard Error 95.5
Small SJLFood Consumption - Calories (Grams/Day)3 months823.8 grams/dayStandard Error 32
Small SJLFood Consumption - Calories (Grams/Day)6 months937.7 grams/dayStandard Error 30.6
Large SJLFood Consumption - Calories (Grams/Day)Baseline2565.6 grams/dayStandard Error 130
Large SJLFood Consumption - Calories (Grams/Day)3 months889.7 grams/dayStandard Error 34.2
Large SJLFood Consumption - Calories (Grams/Day)6 months1091.9 grams/dayStandard Error 39
Secondary

Food Consumption - Carbohydrate (Grams/Day)

The food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).

Time frame: Baseline, 3 and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of food consumption of the carbohydrate in the preoperative evaluation and in the third and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLFood Consumption - Carbohydrate (Grams/Day)3 months61 grams/dayStandard Error 3.1
Small SJLFood Consumption - Carbohydrate (Grams/Day)6 months68.8 grams/dayStandard Error 3.5
Small SJLFood Consumption - Carbohydrate (Grams/Day)Baseline229.0 grams/dayStandard Error 9.4
Large SJLFood Consumption - Carbohydrate (Grams/Day)3 months70.7 grams/dayStandard Error 3.7
Large SJLFood Consumption - Carbohydrate (Grams/Day)6 months77.7 grams/dayStandard Error 3.8
Large SJLFood Consumption - Carbohydrate (Grams/Day)Baseline261.4 grams/dayStandard Error 13.7
Secondary

Food Consumption - Monounsaturated Fat (Grams/Day)

The food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).

Time frame: Baseline, 3 and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of food consumption of Monounsaturated fat in the preoperative evaluation and in the third and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLFood Consumption - Monounsaturated Fat (Grams/Day)Baseline30.1 grams/dayStandard Error 1.9
Small SJLFood Consumption - Monounsaturated Fat (Grams/Day)3 months10.0 grams/dayStandard Error 0.6
Small SJLFood Consumption - Monounsaturated Fat (Grams/Day)6 months12.8 grams/dayStandard Error 0.5
Large SJLFood Consumption - Monounsaturated Fat (Grams/Day)Baseline34.5 grams/dayStandard Error 1.9
Large SJLFood Consumption - Monounsaturated Fat (Grams/Day)3 months10.2 grams/dayStandard Error 0.6
Large SJLFood Consumption - Monounsaturated Fat (Grams/Day)6 months15.6 grams/dayStandard Error 0.9
Secondary

Food Consumption - Polyunsaturated Fat (Grams/Day)

The food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).

Time frame: Baseline, 3 and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of food consumption of Polyunsaturated fat in the preoperative evaluation and in the third and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLFood Consumption - Polyunsaturated Fat (Grams/Day)3 months4.5 grams/dayStandard Error 0.2
Small SJLFood Consumption - Polyunsaturated Fat (Grams/Day)Baseline12.9 grams/dayStandard Error 0.9
Small SJLFood Consumption - Polyunsaturated Fat (Grams/Day)6 months5.9 grams/dayStandard Error 0.3
Large SJLFood Consumption - Polyunsaturated Fat (Grams/Day)Baseline15.9 grams/dayStandard Error 1.2
Large SJLFood Consumption - Polyunsaturated Fat (Grams/Day)3 months5.0 grams/dayStandard Error 0.3
Large SJLFood Consumption - Polyunsaturated Fat (Grams/Day)6 months7.8 grams/dayStandard Error 0.5
Secondary

Food Consumption - Total Fat (Grams/Day)

The food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).

Time frame: Baseline, 3 and 6 months

Population: Generalised estimating equations with gamma distribution and adjusted for possible confounding factors were used to examine the effect of SJL exposure level (large or small) between these factors on the evolution of food consumption of total fat in the preoperative evaluation and in the third and sixth months after the surgical intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Small SJLFood Consumption - Total Fat (Grams/Day)Baseline97.3 grams/dayStandard Error 5.6
Small SJLFood Consumption - Total Fat (Grams/Day)3 months32.2 grams/dayStandard Error 1.7
Small SJLFood Consumption - Total Fat (Grams/Day)6 months40.2 grams/dayStandard Error 1.7
Large SJLFood Consumption - Total Fat (Grams/Day)Baseline116.5 grams/dayStandard Error 7.4
Large SJLFood Consumption - Total Fat (Grams/Day)3 months33.2 grams/dayStandard Error 1.9
Large SJLFood Consumption - Total Fat (Grams/Day)6 months49.5 grams/dayStandard Error 2.4

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026